India approves AstraZeneca coronavirus vaccine, country's first
India on Friday approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, a government minister confirmed on Saturday.
India on Friday approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, a government minister confirmed on Saturday.
The approval paves the way for its rollout in the world’s second worst affected country.
See Zee Business Live TV Streaming Below:
A representative of India’s Central Drugs Standard Control Organization (CDSCO), whose experts are meeting for the second time this week and also considering two other vaccines, declined to comment.
Britain and Argentina have already authorized the vaccine for urgent public use.
India wants to start administering the shots soon.
It is also considering emergency-use authorization applications for vaccines made by Pfizer Inc with Germany’s BioNTech, and by India’s Bharat Biotech.
The story has been taken from a news agency
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Senior Citizen Latest FD Rates: Know what major banks like SBI, PNB, Canara Bank, HDFC Bank, ICICI Bank are providing on fixed deposits
Gratuity Calculator: Rs 38,000 as last-drawn basic salary, 5 years and 5 months of service; what will be gratuity amount?
EPFO Pension Schemes: Early pension, retirement pension, nominee pension and 4 other pension schemes that every private sector employee should know
Top 5 Small Cap Mutual Funds with best SIP returns in 1 year: See how Rs 25,000 monthly investment has grown in each scheme
Top 7 SBI Mutual Funds With Best SIP Returns in 1 Year: Rs 25,000 monthly SIP investment in No.1 fund has jumped to Rs 3,58,404
04:28 PM IST